| KT group n = 25 | Placebo group n = 25 | ANCOVA | ||||||
---|---|---|---|---|---|---|---|---|---|
baseline | Day 12 | Day 30 | p | baseline | Day 12 | Day 30 | P | p-Value | |
DASH | 41.6 ± 10.84 | 33.16 ± 12.87 | 32.65 ± 13.9 | 0.001 | 44.55 ± 12.67 | 34.62 ± 16.68 | 34.65 ± 13.9 | < 0.001 | 0.8 |
VASr | 1.48 ± 1.75 | 0.72 ± 1.3 | 0.6 ± 1.08 | 0.012 | 1.64 ± 1.65 | 1.2 ± 1.35 | 1.12 ± 1.5 | 0.019 | 0.45 |
VASm | 4.6 ± 0.81 | 3.16 ± 1.37 | 2.6 ± 1.41 | < 0.001 | 4.6 ± 0,91 | 3.28 ± 1.64 | 3.44 ± 1.78 | < 0.001 | 0.049 |
VASn | 3.6 ± 1.97 | 2.68 ± 1.93 | 2.16 ± 1.79 | < 0.001 | 3.8 ± 1.61 | 2.8 ± 1.63 | 2.48 ± 1.87 | < 0.001 | 0.78 |